SABCS25 – Group 5D: HER2+ Locally Advanced and Metastatic Breast Cancer; Antibody-drug Conjugates; Treatment Resistance
SABCS25 – Group 5C: Metastatic Breast Cancer; Antibody-drug Conjugates; Treatment Response and Resistance
SABCS25 – Group 4E: HR+ Locally Advanced and Metastatic Breast Cancer; PIK3CA Mutations; Treatment Resistance
SABCS25 – Group 4D: Triple Negative Locally Advanced and Metastatic Breast Cancer; Antibody-drug Conjugates; Immunotherapy
SABCS25 – Group 4A: HER2+ and HER2-low Metastatic Breast Cancer; Antibody-drug Conjugates; Treatment Resistance